Position in GILD
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$972,059
+$91,380 QoQ
Shares Held
7,694
+21.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,081
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CENTAURUS FINANCIAL, INC. holds $28,490,833 across 13 Drug Manufacturers - General names. GILD ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,081 | $14,490,315 | |
| 2 | ABBV |
AbbVie Inc.
|
13,295 | $3,345,553 | |
| 3 | JNJ |
Johnson & Johnson
|
12,384 | $3,145,164 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,912 | $1,530,692 | |
| 5 | AMGN |
Amgen Inc
|
3,413 | $1,235,915 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
7,694 | $972,059 | |
| 7 | NVS |
Novartis AG
|
5,748 | $900,826 | |
| 8 | PFE |
Pfizer Inc
|
36,772 | $885,469 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $972,059 | 7,694 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $880,679 | 6,319 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $649,908 | 5,295 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $776,112 | 6,992 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $645,706 | 5,824 | Shares | Sole | 2025-08-29 | |
| 2025-03-31 | $570,670 | 5,093 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $449,102 | 4,862 | Shares | Sole | 2025-03-12 | |
| 2024-09-30 | $295,955 | 3,530 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $329,190 | 4,798 | Shares | Sole | 2024-09-23 | |
| 2024-03-31 | $312,704 | 4,269 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $448,876 | 5,541 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $465,752 | 6,215 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $389,974 | 5,060 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $644,013 | 7,762 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $601,465 | 7,006 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $546,264 | 8,855 | Shares | Sole | 2022-12-05 | |
| 2022-06-30 | $541,146 | 8,755 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $628,802 | 10,577 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $724,720 | 9,981 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $821,436 | 11,760 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $794,093 | 11,532 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $642,745 | 9,945 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $411,432 | 7,062 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $503,434 | 7,967 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,018,223 | 13,234 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $470,763 | 6,297 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||